These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2002748)

  • 1. Effects of tobacco smoke constituents on MPTP-induced toxicity and monoamine oxidase activity in the mouse brain.
    Carr LA; Basham JK
    Life Sci; 1991; 48(12):1173-7. PubMed ID: 2002748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoamine oxidase B, smoking, and Parkinson's disease.
    Yong VW; Perry TL
    J Neurol Sci; 1986 Feb; 72(2-3):265-72. PubMed ID: 3486945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity: partial protection against striato-nigral dopamine depletion in C57BL/6J mice by cigarette smoke exposure and by beta-naphthoflavone-pretreatment.
    Shahi GS; Das NP; Moochhala SM
    Neurosci Lett; 1991 Jun; 127(2):247-50. PubMed ID: 1881637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity by tobacco smoke.
    Carr LA; Rowell PP
    Neuropharmacology; 1990 Mar; 29(3):311-4. PubMed ID: 2325834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of two 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs, 1-methyl-4-(2-thienyl)-1,2,3,6-tetrahydropyridine and 1-methyl-4-(3-thienyl)-1,2,3,6-tetrahydropyridine, on monoamine oxidase in vitro and on dopamine in mouse brain.
    Fuller RW; Robertson DW; Hemrick-Luecke SK
    J Pharmacol Exp Ther; 1987 Feb; 240(2):415-20. PubMed ID: 3100775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunity of fetal mice to prenatal administration of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Melamed E; Rosenthal J; Youdim MB
    J Neurochem; 1990 Oct; 55(4):1427-31. PubMed ID: 2398363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deprenyl antagonizes acute lethality of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
    Fuller RW; Hemrick-Luecke SK; Perry KW
    J Pharmacol Exp Ther; 1988 Nov; 247(2):531-5. PubMed ID: 3141609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-Naphthylamine, a compound found in cigarette smoke, decreases both monoamine oxidase A and B catalytic activity.
    Hauptmann N; Shih JC
    Life Sci; 2001 Feb; 68(11):1231-41. PubMed ID: 11233991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance of golden hamster to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: relationship with low levels of regional monoamine oxidase B.
    Mitra N; Mohanakumar KP; Ganguly DK
    J Neurochem; 1994 May; 62(5):1906-12. PubMed ID: 8158138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of uptake of 1-methyl-4-phenylpyridinium ion and dopamine in striatal synaptosomes by tobacco smoke components.
    Carr LA; Basham JK; York BK; Rowell PP
    Eur J Pharmacol; 1992 May; 215(2-3):285-7. PubMed ID: 1396992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different effects of monoamine oxidase inhibition on MPTP depletion of heart and brain catecholamines in mice.
    Fuller RW; Hemrick-Luecke SK; Kindt MV; Heikkila RE
    Life Sci; 1988; 42(3):263-71. PubMed ID: 3121972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Participation of brain monoamine oxidase B form in the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: relationship between the enzyme inhibition and the neurotoxicity.
    Kinemuchi H; Arai Y; Toyoshima Y
    Neurosci Lett; 1985 Jul; 58(2):195-200. PubMed ID: 3876524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of MAO in MPTP toxicity--a review.
    Glover V; Gibb C; Sandler M
    J Neural Transm Suppl; 1986; 20():65-76. PubMed ID: 3091762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity study of the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity. I. Evaluation of the biological activity of MPTP analogs.
    Youngster SK; Sonsalla PK; Sieber BA; Heikkila RE
    J Pharmacol Exp Ther; 1989 Jun; 249(3):820-8. PubMed ID: 2786564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of monoamine oxidase enzymes in the action of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine, a selective neurotoxin, in the squirrel monkey: binding and biochemical studies.
    Del Zompo M; Piccardi MP; Bernardi F; Bonuccelli U; Corsini GU
    Brain Res; 1986 Jul; 378(2):320-4. PubMed ID: 3089539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoamine oxidase B(MAO-B) is the major catalyst for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) oxidation in human brain and other tissues.
    Glover V; Gibb C; Sandler M
    Neurosci Lett; 1986 Feb; 64(2):216-20. PubMed ID: 3083305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-dependent effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): correlation with monoamine oxidase-B.
    Walsh SL; Wagner GC
    Synapse; 1989; 3(4):308-14. PubMed ID: 2787063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to toxic pyridinium cations by monoamine oxidase (MAO) enzymes and its use to search for new MAO inhibitors and protective agents.
    Herraiz T
    J Enzyme Inhib Med Chem; 2012 Dec; 27(6):810-7. PubMed ID: 21992679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of types A and B monoamine oxidase by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Fuller RW; Hemrick-Luecke SK
    J Pharmacol Exp Ther; 1985 Mar; 232(3):696-701. PubMed ID: 3871853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of chronic oral nicotine on dopaminergic function in the MPTP-treated mouse.
    Sershen H; Hashim A; Wiener HL; Lajtha A
    Neurosci Lett; 1988 Nov; 93(2-3):270-4. PubMed ID: 3266524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.